Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights

Tango Therapeutics, Inc. (TNGX) Tops Q4 EPS by 3c

March 27, 2023 7:27 AM EDT

Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q4 EPS of ($0.33), $0.03 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $6.41 million versus the consensus estimate of $6.32 million.

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.

... More